nodes	percent_of_prediction	percent_of_DWPC	metapath
Octreotide—SSTR2—SIDS Susceptibility Pathways—HDAC9—glaucoma	0.00235	0.00841	CbGpPWpGaD
Octreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.00232	0.0083	CbGpPWpGaD
Octreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.00226	0.0081	CbGpPWpGaD
Octreotide—SSTR3—GPCR ligand binding—OPN4—glaucoma	0.00225	0.00806	CbGpPWpGaD
Octreotide—MPO—Vitamin B12 Metabolism—SOD1—glaucoma	0.00219	0.00783	CbGpPWpGaD
Octreotide—SSTR1—GPCR ligand binding—OPN4—glaucoma	0.00216	0.00773	CbGpPWpGaD
Octreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.00209	0.00748	CbGpPWpGaD
Octreotide—SSTR1—SIDS Susceptibility Pathways—NTRK2—glaucoma	0.00205	0.00735	CbGpPWpGaD
Octreotide—SSTR3—GPCR ligand binding—PTGFR—glaucoma	0.00203	0.00726	CbGpPWpGaD
Octreotide—MPO—Folate Metabolism—ABCA1—glaucoma	0.002	0.00715	CbGpPWpGaD
Octreotide—SSTR1—GPCR ligand binding—PTGFR—glaucoma	0.00194	0.00696	CbGpPWpGaD
Octreotide—SSTR5—GPCR ligand binding—OPN4—glaucoma	0.00191	0.00685	CbGpPWpGaD
Octreotide—MPO—Folate Metabolism—SOD1—glaucoma	0.00178	0.00637	CbGpPWpGaD
Octreotide—SSTR2—GPCR ligand binding—OPN4—glaucoma	0.00177	0.00632	CbGpPWpGaD
Octreotide—SSTR4—Peptide ligand-binding receptors—EDN1—glaucoma	0.00174	0.00623	CbGpPWpGaD
Octreotide—MPO—Vitamin B12 Metabolism—MTHFR—glaucoma	0.00173	0.00621	CbGpPWpGaD
Octreotide—SSTR5—GPCR ligand binding—PTGFR—glaucoma	0.00172	0.00617	CbGpPWpGaD
Octreotide—SSTR2—SIDS Susceptibility Pathways—NTRK2—glaucoma	0.00168	0.00602	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—OPN4—glaucoma	0.00168	0.00601	CbGpPWpGaD
Octreotide—MPO—Vitamin B12 Metabolism—APOE—glaucoma	0.00161	0.00578	CbGpPWpGaD
Octreotide—SSTR2—GPCR ligand binding—PTGFR—glaucoma	0.00159	0.00569	CbGpPWpGaD
Octreotide—MPO—Selenium Micronutrient Network—ABCA1—glaucoma	0.00159	0.00568	CbGpPWpGaD
Octreotide—SSTR1—SIDS Susceptibility Pathways—BDNF—glaucoma	0.00153	0.00549	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—OPN4—glaucoma	0.00152	0.00546	CbGpPWpGaD
Octreotide—SSTR4—Peptide ligand-binding receptors—C3—glaucoma	0.00152	0.00544	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—PTGFR—glaucoma	0.00151	0.00541	CbGpPWpGaD
Octreotide—SSTR1—SIDS Susceptibility Pathways—IL1A—glaucoma	0.00147	0.00527	CbGpPWpGaD
Octreotide—MPO—Selenium Micronutrient Network—SOD1—glaucoma	0.00141	0.00506	CbGpPWpGaD
Octreotide—MPO—Folate Metabolism—MTHFR—glaucoma	0.00141	0.00505	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—PTGFR—glaucoma	0.00137	0.00491	CbGpPWpGaD
Octreotide—SSTR1—SIDS Susceptibility Pathways—NGF—glaucoma	0.00136	0.00487	CbGpPWpGaD
Octreotide—SSTR1—SIDS Susceptibility Pathways—NR3C1—glaucoma	0.00135	0.00485	CbGpPWpGaD
Octreotide—SSTR4—GPCR ligand binding—SMO—glaucoma	0.00135	0.00483	CbGpPWpGaD
Octreotide—SSTR3—Peptide ligand-binding receptors—EDN1—glaucoma	0.00132	0.00472	CbGpPWpGaD
Octreotide—MPO—C-MYB transcription factor network—GSTM1—glaucoma	0.00132	0.00471	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—LRP12—glaucoma	0.0013	0.00465	CbGpPWpGaD
Octreotide—SSTR4—G alpha (i) signalling events—C3—glaucoma	0.00128	0.00459	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—OPN4—glaucoma	0.00127	0.00455	CbGpPWpGaD
Octreotide—SSTR1—Peptide ligand-binding receptors—EDN1—glaucoma	0.00127	0.00453	CbGpPWpGaD
Octreotide—SSTR2—SIDS Susceptibility Pathways—BDNF—glaucoma	0.00126	0.00449	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—OPN4—glaucoma	0.00122	0.00437	CbGpPWpGaD
Octreotide—SSTR2—SIDS Susceptibility Pathways—IL1A—glaucoma	0.00121	0.00431	CbGpPWpGaD
Octreotide—SSTR4—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.00117	0.00418	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—OPN4—glaucoma	0.00116	0.00414	CbGpPWpGaD
Octreotide—SSTR3—Peptide ligand-binding receptors—C3—glaucoma	0.00115	0.00413	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—PTGFR—glaucoma	0.00115	0.0041	CbGpPWpGaD
Octreotide—SSTR5—Peptide ligand-binding receptors—EDN1—glaucoma	0.00112	0.00402	CbGpPWpGaD
Octreotide—MPO—Selenium Micronutrient Network—MTHFR—glaucoma	0.00112	0.00401	CbGpPWpGaD
Octreotide—SSTR2—SIDS Susceptibility Pathways—NGF—glaucoma	0.00111	0.00399	CbGpPWpGaD
Octreotide—SSTR2—SIDS Susceptibility Pathways—NR3C1—glaucoma	0.00111	0.00397	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—OPN4—glaucoma	0.00111	0.00397	CbGpPWpGaD
Octreotide—SSTR1—Peptide ligand-binding receptors—C3—glaucoma	0.00111	0.00396	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—PTGFR—glaucoma	0.0011	0.00393	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—OPN4—glaucoma	0.00108	0.00387	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—PTGFR—glaucoma	0.00104	0.00372	CbGpPWpGaD
Octreotide—SSTR2—Peptide ligand-binding receptors—EDN1—glaucoma	0.00104	0.00371	CbGpPWpGaD
Octreotide—SSTR3—GPCR ligand binding—SMO—glaucoma	0.00102	0.00366	CbGpPWpGaD
Octreotide—SSTR4—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.00102	0.00365	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—OPN4—glaucoma	0.000999	0.00357	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—PTGFR—glaucoma	0.000998	0.00357	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—LRP12—glaucoma	0.000985	0.00352	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—OPN4—glaucoma	0.000983	0.00352	CbGpPWpGaD
Octreotide—SSTR5—Peptide ligand-binding receptors—C3—glaucoma	0.00098	0.00351	CbGpPWpGaD
Octreotide—SSTR1—GPCR ligand binding—SMO—glaucoma	0.00098	0.00351	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—PTGFR—glaucoma	0.000974	0.00349	CbGpPWpGaD
Octreotide—SSTR3—G alpha (i) signalling events—C3—glaucoma	0.000973	0.00348	CbGpPWpGaD
Octreotide—MPO—IL23-mediated signaling events—TNF—glaucoma	0.000965	0.00346	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—LRP12—glaucoma	0.000944	0.00338	CbGpPWpGaD
Octreotide—SSTR1—G alpha (i) signalling events—C3—glaucoma	0.000932	0.00334	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—OPN4—glaucoma	0.000907	0.00325	CbGpPWpGaD
Octreotide—SSTR2—Peptide ligand-binding receptors—C3—glaucoma	0.000905	0.00324	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—OPN4—glaucoma	0.000901	0.00322	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—PTGFR—glaucoma	0.000899	0.00322	CbGpPWpGaD
Octreotide—SSTR4—GPCR ligand binding—EDN1—glaucoma	0.000889	0.00318	CbGpPWpGaD
Octreotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.000885	0.00317	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—PTGFR—glaucoma	0.000885	0.00317	CbGpPWpGaD
Octreotide—SSTR5—GPCR ligand binding—SMO—glaucoma	0.000869	0.00311	CbGpPWpGaD
Octreotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.000849	0.00304	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—LRP12—glaucoma	0.000837	0.003	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—HEYL—glaucoma	0.000837	0.003	CbGpPWpGaD
Octreotide—SSTR5—G alpha (i) signalling events—C3—glaucoma	0.000827	0.00296	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—PTGFR—glaucoma	0.000816	0.00292	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—PTGFR—glaucoma	0.000811	0.0029	CbGpPWpGaD
Octreotide—SSTR2—GPCR ligand binding—SMO—glaucoma	0.000802	0.00287	CbGpPWpGaD
Octreotide—MPO—C-MYB transcription factor network—CDKN2A—glaucoma	0.000794	0.00284	CbGpPWpGaD
Octreotide—SSTR4—GPCR ligand binding—C3—glaucoma	0.000777	0.00278	CbGpPWpGaD
Octreotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.000773	0.00277	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—LRP12—glaucoma	0.000773	0.00277	CbGpPWpGaD
Octreotide—SSTR2—G alpha (i) signalling events—C3—glaucoma	0.000763	0.00273	CbGpPWpGaD
Octreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.000753	0.00269	CbGpPWpGaD
Octreotide—MPO—Vitamin B12 Metabolism—TNF—glaucoma	0.000747	0.00267	CbGpPWpGaD
Octreotide—MPO—C-MYB transcription factor network—PTGS2—glaucoma	0.000742	0.00266	CbGpPWpGaD
Octreotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.000741	0.00265	CbGpPWpGaD
Octreotide—MPO—Selenium Micronutrient Network—PTGS2—glaucoma	0.000715	0.00256	CbGpPWpGaD
Octreotide—MPO—C-MYB transcription factor network—CDKN1B—glaucoma	0.000703	0.00252	CbGpPWpGaD
Octreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.000695	0.00249	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—SMO—glaucoma	0.000692	0.00248	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—OPN4—glaucoma	0.000683	0.00244	CbGpPWpGaD
Octreotide—SSTR3—GPCR ligand binding—EDN1—glaucoma	0.000674	0.00241	CbGpPWpGaD
Octreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.000657	0.00235	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—OPN4—glaucoma	0.000654	0.00234	CbGpPWpGaD
Octreotide—SSTR1—SIDS Susceptibility Pathways—VEGFA—glaucoma	0.00065	0.00233	CbGpPWpGaD
Octreotide—SSTR1—GPCR ligand binding—EDN1—glaucoma	0.000646	0.00231	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—RPTOR—glaucoma	0.000635	0.00227	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—HEYL—glaucoma	0.000635	0.00227	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—NCK2—glaucoma	0.000615	0.0022	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PTGFR—glaucoma	0.000615	0.0022	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—HEYL—glaucoma	0.000608	0.00218	CbGpPWpGaD
Octreotide—MPO—Folate Metabolism—TNF—glaucoma	0.000608	0.00217	CbGpPWpGaD
Octreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.000607	0.00217	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PTGFR—glaucoma	0.000589	0.00211	CbGpPWpGaD
Octreotide—SSTR3—GPCR ligand binding—C3—glaucoma	0.000589	0.00211	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—OPN4—glaucoma	0.00058	0.00208	CbGpPWpGaD
Octreotide—SSTR5—GPCR ligand binding—EDN1—glaucoma	0.000573	0.00205	CbGpPWpGaD
Octreotide—SSTR1—GPCR ligand binding—C3—glaucoma	0.000565	0.00202	CbGpPWpGaD
Octreotide—SSTR1—SIDS Susceptibility Pathways—TNF—glaucoma	0.000557	0.00199	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—HEYL—glaucoma	0.00054	0.00193	CbGpPWpGaD
Octreotide—MPO—Folate Metabolism—TP53—glaucoma	0.000536	0.00192	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—OPN4—glaucoma	0.000536	0.00192	CbGpPWpGaD
Octreotide—SSTR2—SIDS Susceptibility Pathways—VEGFA—glaucoma	0.000532	0.0019	CbGpPWpGaD
Octreotide—SSTR2—GPCR ligand binding—EDN1—glaucoma	0.000529	0.00189	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—SMO—glaucoma	0.000525	0.00188	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PTGFR—glaucoma	0.000523	0.00187	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—HDAC9—glaucoma	0.000523	0.00187	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—SMO—glaucoma	0.000503	0.0018	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—EDN1—glaucoma	0.000503	0.0018	CbGpPWpGaD
Octreotide—SSTR5—GPCR ligand binding—C3—glaucoma	0.000501	0.00179	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—HEYL—glaucoma	0.000498	0.00178	CbGpPWpGaD
Octreotide—MPO—Selenium Micronutrient Network—TNF—glaucoma	0.000483	0.00173	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PTGFR—glaucoma	0.000482	0.00173	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—RPTOR—glaucoma	0.000481	0.00172	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—NCK2—glaucoma	0.000466	0.00167	CbGpPWpGaD
Octreotide—SSTR2—GPCR ligand binding—C3—glaucoma	0.000462	0.00165	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—RPTOR—glaucoma	0.000461	0.00165	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—EDN1—glaucoma	0.000456	0.00163	CbGpPWpGaD
Octreotide—SSTR2—SIDS Susceptibility Pathways—TNF—glaucoma	0.000456	0.00163	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—NCK2—glaucoma	0.000447	0.0016	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—SMO—glaucoma	0.000446	0.0016	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—C3—glaucoma	0.000439	0.00157	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—SMO—glaucoma	0.000412	0.00147	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—RPTOR—glaucoma	0.000409	0.00146	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—SMO—glaucoma	0.000409	0.00146	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—C3—glaucoma	0.000399	0.00143	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—NCK2—glaucoma	0.000396	0.00142	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—HDAC9—glaucoma	0.000396	0.00142	CbGpPWpGaD
Octreotide—Immune system disorder—Betaxolol—glaucoma	0.000384	0.000533	CcSEcCtD
Octreotide—Diarrhoea—Apraclonidine—glaucoma	0.000384	0.000533	CcSEcCtD
Octreotide—Malaise—Clonidine—glaucoma	0.000383	0.000532	CcSEcCtD
Octreotide—Dyspepsia—Pilocarpine—glaucoma	0.000383	0.000531	CcSEcCtD
Octreotide—Syncope—Clonidine—glaucoma	0.000381	0.000529	CcSEcCtD
Octreotide—SSTR3—GPCR downstream signaling—EDN1—glaucoma	0.000381	0.00136	CbGpPWpGaD
Octreotide—Arrhythmia—Betaxolol—glaucoma	0.00038	0.000527	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—HDAC9—glaucoma	0.00038	0.00136	CbGpPWpGaD
Octreotide—Feeling abnormal—Dorzolamide—glaucoma	0.000379	0.000526	CcSEcCtD
Octreotide—Decreased appetite—Pilocarpine—glaucoma	0.000378	0.000524	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—RPTOR—glaucoma	0.000377	0.00135	CbGpPWpGaD
Octreotide—Feeling abnormal—Travoprost—glaucoma	0.000377	0.000524	CcSEcCtD
Octreotide—Conjunctivitis—Timolol—glaucoma	0.000376	0.000522	CcSEcCtD
Octreotide—Gastrointestinal pain—Dorzolamide—glaucoma	0.000376	0.000522	CcSEcCtD
Octreotide—Alopecia—Betaxolol—glaucoma	0.000376	0.000522	CcSEcCtD
Octreotide—Palpitations—Clonidine—glaucoma	0.000376	0.000522	CcSEcCtD
Octreotide—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000375	0.000521	CcSEcCtD
Octreotide—Gastrointestinal pain—Travoprost—glaucoma	0.000374	0.00052	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—NTRK2—glaucoma	0.000374	0.00134	CbGpPWpGaD
Octreotide—Loss of consciousness—Clonidine—glaucoma	0.000374	0.000519	CcSEcCtD
Octreotide—Feeling abnormal—Brinzolamide—glaucoma	0.000373	0.000517	CcSEcCtD
Octreotide—Mental disorder—Betaxolol—glaucoma	0.000373	0.000517	CcSEcCtD
Octreotide—Constipation—Pilocarpine—glaucoma	0.000372	0.000516	CcSEcCtD
Octreotide—Pain—Pilocarpine—glaucoma	0.000372	0.000516	CcSEcCtD
Octreotide—Cough—Clonidine—glaucoma	0.000371	0.000515	CcSEcCtD
Octreotide—Dizziness—Apraclonidine—glaucoma	0.000371	0.000515	CcSEcCtD
Octreotide—Malnutrition—Betaxolol—glaucoma	0.00037	0.000514	CcSEcCtD
Octreotide—Erythema—Betaxolol—glaucoma	0.00037	0.000514	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—NCK2—glaucoma	0.000366	0.00131	CbGpPWpGaD
Octreotide—Urticaria—Dorzolamide—glaucoma	0.000365	0.000507	CcSEcCtD
Octreotide—SSTR1—GPCR downstream signaling—EDN1—glaucoma	0.000365	0.00131	CbGpPWpGaD
Octreotide—Epistaxis—Timolol—glaucoma	0.000365	0.000507	CcSEcCtD
Octreotide—Body temperature increased—Dorzolamide—glaucoma	0.000364	0.000505	CcSEcCtD
Octreotide—Abdominal pain—Dorzolamide—glaucoma	0.000364	0.000505	CcSEcCtD
Octreotide—Tension—Betaxolol—glaucoma	0.000363	0.000504	CcSEcCtD
Octreotide—Sinusitis—Timolol—glaucoma	0.000363	0.000504	CcSEcCtD
Octreotide—Arthralgia—Clonidine—glaucoma	0.000362	0.000502	CcSEcCtD
Octreotide—Chest pain—Clonidine—glaucoma	0.000362	0.000502	CcSEcCtD
Octreotide—Abdominal pain—Travoprost—glaucoma	0.000362	0.000502	CcSEcCtD
Octreotide—Anxiety—Clonidine—glaucoma	0.000361	0.000501	CcSEcCtD
Octreotide—Asthenia—Acetazolamide—glaucoma	0.00036	0.0005	CcSEcCtD
Octreotide—Dizziness—Bimatoprost—glaucoma	0.00036	0.000499	CcSEcCtD
Octreotide—Nervousness—Betaxolol—glaucoma	0.00036	0.000499	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.00036	0.000499	CcSEcCtD
Octreotide—Urticaria—Brinzolamide—glaucoma	0.000359	0.000498	CcSEcCtD
Octreotide—Feeling abnormal—Pilocarpine—glaucoma	0.000358	0.000497	CcSEcCtD
Octreotide—Discomfort—Clonidine—glaucoma	0.000358	0.000496	CcSEcCtD
Octreotide—Vomiting—Apraclonidine—glaucoma	0.000357	0.000495	CcSEcCtD
Octreotide—Muscle spasms—Betaxolol—glaucoma	0.000356	0.000494	CcSEcCtD
Octreotide—Gastrointestinal pain—Pilocarpine—glaucoma	0.000355	0.000493	CcSEcCtD
Octreotide—Hypersensitivity—Brimonidine—glaucoma	0.000355	0.000492	CcSEcCtD
Octreotide—Dry mouth—Clonidine—glaucoma	0.000354	0.000491	CcSEcCtD
Octreotide—Bradycardia—Timolol—glaucoma	0.000354	0.000491	CcSEcCtD
Octreotide—Dermatitis—Apraclonidine—glaucoma	0.000353	0.00049	CcSEcCtD
Octreotide—Headache—Apraclonidine—glaucoma	0.000351	0.000488	CcSEcCtD
Octreotide—Vision blurred—Betaxolol—glaucoma	0.000349	0.000484	CcSEcCtD
Octreotide—Rhinitis—Timolol—glaucoma	0.000348	0.000483	CcSEcCtD
Octreotide—Oedema—Clonidine—glaucoma	0.000347	0.000482	CcSEcCtD
Octreotide—Tremor—Betaxolol—glaucoma	0.000347	0.000481	CcSEcCtD
Octreotide—SSTR3—Signaling by GPCR—EDN1—glaucoma	0.000346	0.00124	CbGpPWpGaD
Octreotide—Asthenia—Brimonidine—glaucoma	0.000346	0.00048	CcSEcCtD
Octreotide—Infection—Clonidine—glaucoma	0.000345	0.000478	CcSEcCtD
Octreotide—Abdominal pain—Pilocarpine—glaucoma	0.000344	0.000477	CcSEcCtD
Octreotide—Body temperature increased—Pilocarpine—glaucoma	0.000344	0.000477	CcSEcCtD
Octreotide—Ill-defined disorder—Betaxolol—glaucoma	0.000344	0.000477	CcSEcCtD
Octreotide—Diarrhoea—Acetazolamide—glaucoma	0.000343	0.000476	CcSEcCtD
Octreotide—Rash—Bimatoprost—glaucoma	0.000343	0.000476	CcSEcCtD
Octreotide—Dermatitis—Bimatoprost—glaucoma	0.000343	0.000475	CcSEcCtD
Octreotide—Oedema peripheral—Timolol—glaucoma	0.000342	0.000475	CcSEcCtD
Octreotide—Anaemia—Betaxolol—glaucoma	0.000342	0.000475	CcSEcCtD
Octreotide—Shock—Clonidine—glaucoma	0.000341	0.000474	CcSEcCtD
Octreotide—Pruritus—Brimonidine—glaucoma	0.000341	0.000473	CcSEcCtD
Octreotide—Headache—Bimatoprost—glaucoma	0.000341	0.000473	CcSEcCtD
Octreotide—Nervous system disorder—Clonidine—glaucoma	0.00034	0.000472	CcSEcCtD
Octreotide—Thrombocytopenia—Clonidine—glaucoma	0.00034	0.000472	CcSEcCtD
Octreotide—Hypersensitivity—Dorzolamide—glaucoma	0.000339	0.00047	CcSEcCtD
Octreotide—Tachycardia—Clonidine—glaucoma	0.000339	0.00047	CcSEcCtD
Octreotide—Hypersensitivity—Travoprost—glaucoma	0.000337	0.000468	CcSEcCtD
Octreotide—Skin disorder—Clonidine—glaucoma	0.000337	0.000468	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—HDAC9—glaucoma	0.000337	0.00121	CbGpPWpGaD
Octreotide—Hyperhidrosis—Clonidine—glaucoma	0.000336	0.000466	CcSEcCtD
Octreotide—Visual impairment—Timolol—glaucoma	0.000335	0.000465	CcSEcCtD
Octreotide—Malaise—Betaxolol—glaucoma	0.000334	0.000463	CcSEcCtD
Octreotide—Nausea—Apraclonidine—glaucoma	0.000333	0.000462	CcSEcCtD
Octreotide—Hypersensitivity—Brinzolamide—glaucoma	0.000333	0.000462	CcSEcCtD
Octreotide—SSTR3—GPCR downstream signaling—C3—glaucoma	0.000333	0.00119	CbGpPWpGaD
Octreotide—Vertigo—Betaxolol—glaucoma	0.000333	0.000462	CcSEcCtD
Octreotide—Syncope—Betaxolol—glaucoma	0.000332	0.000461	CcSEcCtD
Octreotide—Dizziness—Acetazolamide—glaucoma	0.000332	0.00046	CcSEcCtD
Octreotide—SSTR1—Signaling by GPCR—EDN1—glaucoma	0.000332	0.00119	CbGpPWpGaD
Octreotide—Anorexia—Clonidine—glaucoma	0.000331	0.000459	CcSEcCtD
Octreotide—Asthenia—Dorzolamide—glaucoma	0.00033	0.000458	CcSEcCtD
Octreotide—Asthenia—Travoprost—glaucoma	0.000329	0.000456	CcSEcCtD
Octreotide—Palpitations—Betaxolol—glaucoma	0.000327	0.000454	CcSEcCtD
Octreotide—Pruritus—Dorzolamide—glaucoma	0.000325	0.000452	CcSEcCtD
Octreotide—Loss of consciousness—Betaxolol—glaucoma	0.000325	0.000452	CcSEcCtD
Octreotide—Asthenia—Brinzolamide—glaucoma	0.000324	0.00045	CcSEcCtD
Octreotide—Pruritus—Travoprost—glaucoma	0.000324	0.00045	CcSEcCtD
Octreotide—Tinnitus—Timolol—glaucoma	0.000324	0.00045	CcSEcCtD
Octreotide—SSTR5—GPCR downstream signaling—EDN1—glaucoma	0.000324	0.00116	CbGpPWpGaD
Octreotide—Cough—Betaxolol—glaucoma	0.000323	0.000448	CcSEcCtD
Octreotide—Nausea—Bimatoprost—glaucoma	0.000323	0.000448	CcSEcCtD
Octreotide—Cardiac disorder—Timolol—glaucoma	0.000322	0.000447	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—NGFR—glaucoma	0.000321	0.00115	CbGpPWpGaD
Octreotide—Hypersensitivity—Pilocarpine—glaucoma	0.00032	0.000444	CcSEcCtD
Octreotide—Pruritus—Brinzolamide—glaucoma	0.00032	0.000444	CcSEcCtD
Octreotide—Vomiting—Acetazolamide—glaucoma	0.000319	0.000443	CcSEcCtD
Octreotide—SSTR1—GPCR downstream signaling—C3—glaucoma	0.000319	0.00114	CbGpPWpGaD
Octreotide—Dizziness—Brimonidine—glaucoma	0.000318	0.000442	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Clonidine—glaucoma	0.000316	0.000439	CcSEcCtD
Octreotide—Chest pain—Betaxolol—glaucoma	0.000315	0.000437	CcSEcCtD
Octreotide—Arthralgia—Betaxolol—glaucoma	0.000315	0.000437	CcSEcCtD
Octreotide—Myalgia—Betaxolol—glaucoma	0.000315	0.000437	CcSEcCtD
Octreotide—Diarrhoea—Dorzolamide—glaucoma	0.000315	0.000437	CcSEcCtD
Octreotide—Headache—Acetazolamide—glaucoma	0.000314	0.000436	CcSEcCtD
Octreotide—Anxiety—Betaxolol—glaucoma	0.000314	0.000436	CcSEcCtD
Octreotide—Insomnia—Clonidine—glaucoma	0.000314	0.000436	CcSEcCtD
Octreotide—Immune system disorder—Timolol—glaucoma	0.000314	0.000436	CcSEcCtD
Octreotide—Diarrhoea—Travoprost—glaucoma	0.000313	0.000435	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000313	0.000434	CcSEcCtD
Octreotide—Asthenia—Pilocarpine—glaucoma	0.000312	0.000433	CcSEcCtD
Octreotide—Paraesthesia—Clonidine—glaucoma	0.000312	0.000432	CcSEcCtD
Octreotide—Discomfort—Betaxolol—glaucoma	0.000311	0.000432	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—HDAC9—glaucoma	0.000311	0.00111	CbGpPWpGaD
Octreotide—Arrhythmia—Timolol—glaucoma	0.00031	0.000431	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—SMO—glaucoma	0.00031	0.00111	CbGpPWpGaD
Octreotide—Dyspnoea—Clonidine—glaucoma	0.000309	0.000429	CcSEcCtD
Octreotide—Diarrhoea—Brinzolamide—glaucoma	0.000309	0.000429	CcSEcCtD
Octreotide—Somnolence—Clonidine—glaucoma	0.000309	0.000428	CcSEcCtD
Octreotide—Dry mouth—Betaxolol—glaucoma	0.000308	0.000428	CcSEcCtD
Octreotide—Pruritus—Pilocarpine—glaucoma	0.000307	0.000427	CcSEcCtD
Octreotide—Alopecia—Timolol—glaucoma	0.000307	0.000426	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—NTRK1—glaucoma	0.000305	0.00109	CbGpPWpGaD
Octreotide—Mental disorder—Timolol—glaucoma	0.000304	0.000422	CcSEcCtD
Octreotide—Dizziness—Dorzolamide—glaucoma	0.000304	0.000422	CcSEcCtD
Octreotide—Rash—Brimonidine—glaucoma	0.000304	0.000421	CcSEcCtD
Octreotide—Dermatitis—Brimonidine—glaucoma	0.000303	0.000421	CcSEcCtD
Octreotide—Dizziness—Travoprost—glaucoma	0.000303	0.00042	CcSEcCtD
Octreotide—Malnutrition—Timolol—glaucoma	0.000302	0.00042	CcSEcCtD
Octreotide—Erythema—Timolol—glaucoma	0.000302	0.00042	CcSEcCtD
Octreotide—SSTR3—Signaling by GPCR—C3—glaucoma	0.000302	0.00108	CbGpPWpGaD
Octreotide—Oedema—Betaxolol—glaucoma	0.000302	0.000419	CcSEcCtD
Octreotide—Headache—Brimonidine—glaucoma	0.000302	0.000419	CcSEcCtD
Octreotide—Decreased appetite—Clonidine—glaucoma	0.000302	0.000419	CcSEcCtD
Octreotide—Infection—Betaxolol—glaucoma	0.0003	0.000417	CcSEcCtD
Octreotide—Gastrointestinal disorder—Clonidine—glaucoma	0.0003	0.000416	CcSEcCtD
Octreotide—Fatigue—Clonidine—glaucoma	0.000299	0.000415	CcSEcCtD
Octreotide—Dizziness—Brinzolamide—glaucoma	0.000299	0.000415	CcSEcCtD
Octreotide—SSTR2—GPCR downstream signaling—EDN1—glaucoma	0.000299	0.00107	CbGpPWpGaD
Octreotide—Nausea—Acetazolamide—glaucoma	0.000298	0.000414	CcSEcCtD
Octreotide—Diarrhoea—Pilocarpine—glaucoma	0.000297	0.000413	CcSEcCtD
Octreotide—Shock—Betaxolol—glaucoma	0.000297	0.000413	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—SMO—glaucoma	0.000297	0.00106	CbGpPWpGaD
Octreotide—Tension—Timolol—glaucoma	0.000297	0.000412	CcSEcCtD
Octreotide—Constipation—Clonidine—glaucoma	0.000297	0.000412	CcSEcCtD
Octreotide—Pain—Clonidine—glaucoma	0.000297	0.000412	CcSEcCtD
Octreotide—Nervous system disorder—Betaxolol—glaucoma	0.000296	0.000411	CcSEcCtD
Octreotide—Thrombocytopenia—Betaxolol—glaucoma	0.000296	0.000411	CcSEcCtD
Octreotide—Tachycardia—Betaxolol—glaucoma	0.000295	0.000409	CcSEcCtD
Octreotide—SSTR5—Signaling by GPCR—EDN1—glaucoma	0.000294	0.00105	CbGpPWpGaD
Octreotide—Nervousness—Timolol—glaucoma	0.000294	0.000408	CcSEcCtD
Octreotide—Skin disorder—Betaxolol—glaucoma	0.000293	0.000407	CcSEcCtD
Octreotide—Vomiting—Dorzolamide—glaucoma	0.000292	0.000406	CcSEcCtD
Octreotide—Hyperhidrosis—Betaxolol—glaucoma	0.000292	0.000405	CcSEcCtD
Octreotide—Rash—Dorzolamide—glaucoma	0.00029	0.000402	CcSEcCtD
Octreotide—Dermatitis—Dorzolamide—glaucoma	0.00029	0.000402	CcSEcCtD
Octreotide—SSTR1—Signaling by GPCR—C3—glaucoma	0.00029	0.00104	CbGpPWpGaD
Octreotide—Rash—Travoprost—glaucoma	0.000289	0.000401	CcSEcCtD
Octreotide—Dermatitis—Travoprost—glaucoma	0.000288	0.0004	CcSEcCtD
Octreotide—Headache—Dorzolamide—glaucoma	0.000288	0.0004	CcSEcCtD
Octreotide—Anorexia—Betaxolol—glaucoma	0.000288	0.0004	CcSEcCtD
Octreotide—Vomiting—Brinzolamide—glaucoma	0.000287	0.000399	CcSEcCtD
Octreotide—Dizziness—Pilocarpine—glaucoma	0.000287	0.000399	CcSEcCtD
Octreotide—Headache—Travoprost—glaucoma	0.000287	0.000398	CcSEcCtD
Octreotide—Nausea—Brimonidine—glaucoma	0.000286	0.000397	CcSEcCtD
Octreotide—Feeling abnormal—Clonidine—glaucoma	0.000286	0.000397	CcSEcCtD
Octreotide—Rash—Brinzolamide—glaucoma	0.000285	0.000396	CcSEcCtD
Octreotide—Vision blurred—Timolol—glaucoma	0.000285	0.000396	CcSEcCtD
Octreotide—Dermatitis—Brinzolamide—glaucoma	0.000285	0.000395	CcSEcCtD
Octreotide—Gastrointestinal pain—Clonidine—glaucoma	0.000284	0.000394	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—NTRK2—glaucoma	0.000283	0.00101	CbGpPWpGaD
Octreotide—Headache—Brinzolamide—glaucoma	0.000283	0.000393	CcSEcCtD
Octreotide—SSTR5—GPCR downstream signaling—C3—glaucoma	0.000283	0.00101	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CDKN2B—glaucoma	0.000281	0.00101	CbGpPWpGaD
Octreotide—Vomiting—Pilocarpine—glaucoma	0.000276	0.000383	CcSEcCtD
Octreotide—Urticaria—Clonidine—glaucoma	0.000276	0.000383	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000275	0.000382	CcSEcCtD
Octreotide—Body temperature increased—Clonidine—glaucoma	0.000274	0.000381	CcSEcCtD
Octreotide—Abdominal pain—Clonidine—glaucoma	0.000274	0.000381	CcSEcCtD
Octreotide—Rash—Pilocarpine—glaucoma	0.000274	0.00038	CcSEcCtD
Octreotide—Dermatitis—Pilocarpine—glaucoma	0.000274	0.00038	CcSEcCtD
Octreotide—Insomnia—Betaxolol—glaucoma	0.000273	0.000379	CcSEcCtD
Octreotide—Nausea—Dorzolamide—glaucoma	0.000273	0.000379	CcSEcCtD
Octreotide—Headache—Pilocarpine—glaucoma	0.000272	0.000378	CcSEcCtD
Octreotide—Nausea—Travoprost—glaucoma	0.000272	0.000377	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—NTRK2—glaucoma	0.000272	0.000973	CbGpPWpGaD
Octreotide—Vertigo—Timolol—glaucoma	0.000272	0.000377	CcSEcCtD
Octreotide—SSTR2—Signaling by GPCR—EDN1—glaucoma	0.000271	0.000971	CbGpPWpGaD
Octreotide—Paraesthesia—Betaxolol—glaucoma	0.000271	0.000377	CcSEcCtD
Octreotide—Syncope—Timolol—glaucoma	0.000271	0.000376	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—EDN1—glaucoma	0.00027	0.000965	CbGpPWpGaD
Octreotide—Dyspnoea—Betaxolol—glaucoma	0.000269	0.000374	CcSEcCtD
Octreotide—Nausea—Brinzolamide—glaucoma	0.000269	0.000373	CcSEcCtD
Octreotide—Palpitations—Timolol—glaucoma	0.000267	0.000371	CcSEcCtD
Octreotide—Dyspepsia—Betaxolol—glaucoma	0.000266	0.000369	CcSEcCtD
Octreotide—Loss of consciousness—Timolol—glaucoma	0.000266	0.000369	CcSEcCtD
Octreotide—Cough—Timolol—glaucoma	0.000264	0.000366	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—SMO—glaucoma	0.000264	0.000943	CbGpPWpGaD
Octreotide—Decreased appetite—Betaxolol—glaucoma	0.000263	0.000365	CcSEcCtD
Octreotide—Hypertension—Timolol—glaucoma	0.000261	0.000362	CcSEcCtD
Octreotide—SSTR2—GPCR downstream signaling—C3—glaucoma	0.000261	0.000935	CbGpPWpGaD
Octreotide—Gastrointestinal disorder—Betaxolol—glaucoma	0.000261	0.000362	CcSEcCtD
Octreotide—Fatigue—Betaxolol—glaucoma	0.000261	0.000362	CcSEcCtD
Octreotide—Constipation—Betaxolol—glaucoma	0.000258	0.000359	CcSEcCtD
Octreotide—Pain—Betaxolol—glaucoma	0.000258	0.000359	CcSEcCtD
Octreotide—Nausea—Pilocarpine—glaucoma	0.000258	0.000358	CcSEcCtD
Octreotide—Myalgia—Timolol—glaucoma	0.000257	0.000357	CcSEcCtD
Octreotide—Chest pain—Timolol—glaucoma	0.000257	0.000357	CcSEcCtD
Octreotide—Arthralgia—Timolol—glaucoma	0.000257	0.000357	CcSEcCtD
Octreotide—SSTR5—Signaling by GPCR—C3—glaucoma	0.000257	0.00092	CbGpPWpGaD
Octreotide—Anxiety—Timolol—glaucoma	0.000257	0.000356	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000256	0.000355	CcSEcCtD
Octreotide—Hypersensitivity—Clonidine—glaucoma	0.000256	0.000355	CcSEcCtD
Octreotide—Discomfort—Timolol—glaucoma	0.000254	0.000353	CcSEcCtD
Octreotide—Dry mouth—Timolol—glaucoma	0.000252	0.000349	CcSEcCtD
Octreotide—Asthenia—Clonidine—glaucoma	0.000249	0.000346	CcSEcCtD
Octreotide—Feeling abnormal—Betaxolol—glaucoma	0.000249	0.000346	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—NGF—glaucoma	0.000248	0.000887	CbGpPWpGaD
Octreotide—Anaphylactic shock—Timolol—glaucoma	0.000247	0.000343	CcSEcCtD
Octreotide—Oedema—Timolol—glaucoma	0.000247	0.000343	CcSEcCtD
Octreotide—Pruritus—Clonidine—glaucoma	0.000246	0.000341	CcSEcCtD
Octreotide—Infection—Timolol—glaucoma	0.000245	0.00034	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—SMO—glaucoma	0.000243	0.00087	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—NGFR—glaucoma	0.000243	0.00087	CbGpPWpGaD
Octreotide—Shock—Timolol—glaucoma	0.000243	0.000337	CcSEcCtD
Octreotide—Nervous system disorder—Timolol—glaucoma	0.000242	0.000336	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—NTRK2—glaucoma	0.000241	0.000863	CbGpPWpGaD
Octreotide—Urticaria—Betaxolol—glaucoma	0.00024	0.000333	CcSEcCtD
Octreotide—Skin disorder—Timolol—glaucoma	0.00024	0.000333	CcSEcCtD
Octreotide—Body temperature increased—Betaxolol—glaucoma	0.000239	0.000331	CcSEcCtD
Octreotide—Hyperhidrosis—Timolol—glaucoma	0.000239	0.000331	CcSEcCtD
Octreotide—Diarrhoea—Clonidine—glaucoma	0.000237	0.00033	CcSEcCtD
Octreotide—SSTR2—Signaling by GPCR—C3—glaucoma	0.000237	0.000849	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—C3—glaucoma	0.000236	0.000843	CbGpPWpGaD
Octreotide—Anorexia—Timolol—glaucoma	0.000235	0.000327	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—NGFR—glaucoma	0.000233	0.000834	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—NTRK1—glaucoma	0.000231	0.000827	CbGpPWpGaD
Octreotide—Dizziness—Clonidine—glaucoma	0.00023	0.000318	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Timolol—glaucoma	0.000225	0.000312	CcSEcCtD
Octreotide—Insomnia—Timolol—glaucoma	0.000223	0.00031	CcSEcCtD
Octreotide—Hypersensitivity—Betaxolol—glaucoma	0.000223	0.000309	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—NTRK2—glaucoma	0.000222	0.000796	CbGpPWpGaD
Octreotide—Paraesthesia—Timolol—glaucoma	0.000222	0.000308	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—NTRK1—glaucoma	0.000222	0.000793	CbGpPWpGaD
Octreotide—Vomiting—Clonidine—glaucoma	0.000221	0.000306	CcSEcCtD
Octreotide—Dyspnoea—Timolol—glaucoma	0.00022	0.000305	CcSEcCtD
Octreotide—Somnolence—Timolol—glaucoma	0.000219	0.000305	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—APOE—glaucoma	0.000219	0.000785	CbGpPWpGaD
Octreotide—Rash—Clonidine—glaucoma	0.000219	0.000304	CcSEcCtD
Octreotide—Dermatitis—Clonidine—glaucoma	0.000219	0.000303	CcSEcCtD
Octreotide—Headache—Clonidine—glaucoma	0.000217	0.000302	CcSEcCtD
Octreotide—Dyspepsia—Timolol—glaucoma	0.000217	0.000302	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—CAV1—glaucoma	0.000217	0.000778	CbGpPWpGaD
Octreotide—Asthenia—Betaxolol—glaucoma	0.000217	0.000301	CcSEcCtD
Octreotide—Decreased appetite—Timolol—glaucoma	0.000215	0.000298	CcSEcCtD
Octreotide—Pruritus—Betaxolol—glaucoma	0.000214	0.000297	CcSEcCtD
Octreotide—Gastrointestinal disorder—Timolol—glaucoma	0.000213	0.000296	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—CDKN2B—glaucoma	0.000213	0.000762	CbGpPWpGaD
Octreotide—Fatigue—Timolol—glaucoma	0.000213	0.000295	CcSEcCtD
Octreotide—Pain—Timolol—glaucoma	0.000211	0.000293	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—NGFR—glaucoma	0.000207	0.00074	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—FN1—glaucoma	0.000207	0.00074	CbGpPWpGaD
Octreotide—Diarrhoea—Betaxolol—glaucoma	0.000207	0.000287	CcSEcCtD
Octreotide—Nausea—Clonidine—glaucoma	0.000206	0.000286	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—EDN1—glaucoma	0.000204	0.000731	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—BAD—glaucoma	0.000204	0.000731	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CDKN2B—glaucoma	0.000204	0.000731	CbGpPWpGaD
Octreotide—Feeling abnormal—Timolol—glaucoma	0.000203	0.000282	CcSEcCtD
Octreotide—Gastrointestinal pain—Timolol—glaucoma	0.000202	0.00028	CcSEcCtD
Octreotide—Dizziness—Betaxolol—glaucoma	0.0002	0.000277	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—NTRK1—glaucoma	0.000196	0.000703	CbGpPWpGaD
Octreotide—Urticaria—Timolol—glaucoma	0.000196	0.000272	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—EDN1—glaucoma	0.000196	0.000701	CbGpPWpGaD
Octreotide—Abdominal pain—Timolol—glaucoma	0.000195	0.000271	CcSEcCtD
Octreotide—Body temperature increased—Timolol—glaucoma	0.000195	0.000271	CcSEcCtD
Octreotide—Vomiting—Betaxolol—glaucoma	0.000192	0.000267	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—NGFR—glaucoma	0.000191	0.000683	CbGpPWpGaD
Octreotide—Rash—Betaxolol—glaucoma	0.000191	0.000264	CcSEcCtD
Octreotide—Dermatitis—Betaxolol—glaucoma	0.00019	0.000264	CcSEcCtD
Octreotide—Headache—Betaxolol—glaucoma	0.000189	0.000263	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—NGF—glaucoma	0.000188	0.000672	CbGpPWpGaD
Octreotide—Hypersensitivity—Timolol—glaucoma	0.000182	0.000252	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—NTRK1—glaucoma	0.000181	0.000649	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CDKN2B—glaucoma	0.000181	0.000648	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—NGF—glaucoma	0.00018	0.000644	CbGpPWpGaD
Octreotide—Nausea—Betaxolol—glaucoma	0.000179	0.000249	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—C3—glaucoma	0.000179	0.000639	CbGpPWpGaD
Octreotide—Asthenia—Timolol—glaucoma	0.000177	0.000246	CcSEcCtD
Octreotide—Pruritus—Timolol—glaucoma	0.000175	0.000242	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—EDN1—glaucoma	0.000174	0.000622	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—C3—glaucoma	0.000171	0.000613	CbGpPWpGaD
Octreotide—Diarrhoea—Timolol—glaucoma	0.000169	0.000234	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—CDKN2B—glaucoma	0.000167	0.000598	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—APOE—glaucoma	0.000166	0.000595	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CAV1—glaucoma	0.000165	0.000589	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—NOS3—glaucoma	0.000164	0.000588	CbGpPWpGaD
Octreotide—Dizziness—Timolol—glaucoma	0.000163	0.000227	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—EDN1—glaucoma	0.00016	0.000574	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—NGF—glaucoma	0.00016	0.000571	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—APOE—glaucoma	0.000159	0.00057	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CAV1—glaucoma	0.000158	0.000565	CbGpPWpGaD
Octreotide—Vomiting—Timolol—glaucoma	0.000157	0.000218	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—FN1—glaucoma	0.000157	0.000561	CbGpPWpGaD
Octreotide—Rash—Timolol—glaucoma	0.000156	0.000216	CcSEcCtD
Octreotide—Dermatitis—Timolol—glaucoma	0.000155	0.000216	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—BAD—glaucoma	0.000155	0.000554	CbGpPWpGaD
Octreotide—Headache—Timolol—glaucoma	0.000155	0.000215	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—C3—glaucoma	0.000152	0.000543	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—FN1—glaucoma	0.00015	0.000538	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—BAD—glaucoma	0.000148	0.000531	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—NGF—glaucoma	0.000147	0.000527	CbGpPWpGaD
Octreotide—Nausea—Timolol—glaucoma	0.000147	0.000203	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—CDKN1B—glaucoma	0.000142	0.000509	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—APOE—glaucoma	0.000141	0.000506	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—C3—glaucoma	0.00014	0.000501	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CAV1—glaucoma	0.00014	0.000501	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—FN1—glaucoma	0.000133	0.000477	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—MMP9—glaucoma	0.000132	0.000472	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—BAD—glaucoma	0.000132	0.000471	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—APOE—glaucoma	0.00013	0.000467	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CAV1—glaucoma	0.000129	0.000462	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—NOS3—glaucoma	0.000125	0.000446	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—FN1—glaucoma	0.000123	0.00044	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—BAD—glaucoma	0.000122	0.000435	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—NOS3—glaucoma	0.000119	0.000427	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—VEGFA—glaucoma	0.000118	0.000424	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CDKN1B—glaucoma	0.000108	0.000386	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—NOS3—glaucoma	0.000106	0.000379	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CDKN1B—glaucoma	0.000103	0.00037	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MMP9—glaucoma	9.99e-05	0.000357	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—NOS3—glaucoma	9.77e-05	0.00035	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MMP9—glaucoma	9.58e-05	0.000343	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CDKN1B—glaucoma	9.17e-05	0.000328	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—VEGFA—glaucoma	8.97e-05	0.000321	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—TP53—glaucoma	8.94e-05	0.00032	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—VEGFA—glaucoma	8.6e-05	0.000308	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MMP9—glaucoma	8.49e-05	0.000304	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CDKN1B—glaucoma	8.46e-05	0.000303	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MMP9—glaucoma	7.84e-05	0.000281	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—VEGFA—glaucoma	7.63e-05	0.000273	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—VEGFA—glaucoma	7.04e-05	0.000252	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—TP53—glaucoma	6.78e-05	0.000243	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—TP53—glaucoma	6.5e-05	0.000233	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—TP53—glaucoma	5.76e-05	0.000206	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—TP53—glaucoma	5.32e-05	0.00019	CbGpPWpGaD
